10 April 2020

• Introduction
  Kerala  has  won Indian Council of Medical Research’s (ICMR) approval for the clinical protocol exploring the feasibility of an experimental therapy, convalescent plasma transfusion, which may be administered to severe COVID-19 patients.
• At present there are no specific antiviral agents which have been found to be effective in the treatment of COVID-19.
• Convalescent plasma therapy is not new and have been used by doctors to treat critically ill patients during earlier epidemics too, during H1N1, SARS and Ebola